|Mr. Timothy C. Crew||CEO & Director||880.3k||N/A||1961|
|Mr. Martin P. Galvan||VP of Fin. & CFO||531.24k||N/A||1952|
|Mr. Samuel H. Israel||Gen. Counsel & Chief Legal Officer||489.67k||N/A||1962|
|Mr. John M. Abt||VP & Chief Quality Operations Officer||386.51k||N/A||1965|
|Mr. John Kozlowski||Chief of Staff & Strategy Officer||424.69k||N/A||1972|
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, suspension, soft gel, and injectable dosages. It also provides its products for various medical indications comprising cholesterol, muscle spasm, pain management, irritable bowel, antipsychosis, gastrointestinal, cardiovascular, thyroid deficiency, central nervous system, urinary, migraine, bronchospasms, and gallstone. In addition, the company manufactures active pharmaceutical ingredients. It markets its products under the Lipitor, Lioresal, Bentyl, Prolixin, MiraLAX, Imdur, Levoxyl/Synthroid, Concerta, Toprol-XL, Prilosec, Ditropan, Protonix, Imitrex, Brethine, and Actigall brands to generic pharmaceutical and private label distributors, drug wholesalers, chain drug retailers, mail-order pharmacies, other pharmaceutical manufacturers, managed care and health maintenance organizations, hospital buying groups, and governmental entities. The company has supply and development agreements with Jerome Stevens Pharmaceuticals, Summit Bioscience LLC, HEC Pharm Group, Andor Pharmaceuticals LLC, Dexcel Pharma, and Aralez Pharmaceuticals. Lannett Company, Inc. was founded in 1942 and is based in Philadelphia, Pennsylvania.
Lannett Company, Inc.’s ISS Governance QualityScore as of June 25, 2019 is 5. The pillar scores are Audit: 5; Board: 7; Shareholder Rights: 2; Compensation: 4.